Special Techniques of Adjuvant Breast Carcinoma Radiotherapy.

accelerated partial breast irradiation adjuvant radiotherapy boost breast cancer

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
31 Dec 2022
Historique:
received: 27 11 2022
revised: 23 12 2022
accepted: 28 12 2022
entrez: 8 1 2023
pubmed: 9 1 2023
medline: 9 1 2023
Statut: epublish

Résumé

Modern radiotherapy techniques are designed to permit reduced irradiation of healthy tissue, resulting in a diminished risk of adverse effects and shortened recovery times. Several randomized studies have demonstrated the benefits of increased dosage to the tumor bed area in combination with whole breast irradiation (WBI). Conventional WBI treatment following breast-conserving procedures, which required 5-7 weeks of daily treatments, has been reduced to 3-4 weeks when using hyperfractionated regimens. The dosage administration improves local control, albeit with poorer cosmesis. The method of accelerated partial breast irradiation (APBI) shortens the treatment period whilst reducing the irradiated volume. APBI can be delivered using intraoperative radiation, brachytherapy, or external beam radiotherapy. Currently available data support the use of external beam partial breast irradiation in selected patients. Modern radiotherapy techniques make it possible to achieve favorable cosmesis in most patients undergoing immediate breast reconstruction surgery, and studies confirm that current methods of external beam radiation allow an acceptable coverage of target volumes both in the reconstructed breast and in the regional lymphatic nodes.

Identifiants

pubmed: 36612294
pii: cancers15010298
doi: 10.3390/cancers15010298
pmc: PMC9818986
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : Ministry of Health, Czech Republic
ID : UHHK 00179906
Organisme : Charles University
ID : Cooperatio, Research Area ONCO
Organisme : Ministry of Defence, Czech Republic
ID : Long Term Development Plan - Medical Aspects of Weapons of Mass Destruction

Références

Clin Oncol (R Coll Radiol). 2021 Jul;33(7):430-439
pubmed: 34023185
Br J Radiol. 2015;88(1056):20150453
pubmed: 26492402
Clin Adv Hematol Oncol. 2006 Oct;4(10):719-21
pubmed: 17111558
J Clin Oncol. 2020 Jul 10;38(20):2329-2340
pubmed: 32442071
Plast Reconstr Surg. 2012 Sep;130(3):503-509
pubmed: 22929235
JCO Oncol Pract. 2021 Dec;17(12):697-706
pubmed: 34652952
Front Oncol. 2020 Jun 26;10:772
pubmed: 32670865
Int J Radiat Oncol Biol Phys. 1995 Sep 30;33(2):245-51
pubmed: 7673011
Int J Radiat Oncol Biol Phys. 2004 Nov 1;60(3):722-30
pubmed: 15465188
Cancer Commun (Lond). 2022 Oct;42(10):913-936
pubmed: 36074908
J Clin Oncol. 2022 Nov 16;:JCO2201565
pubmed: 36383926
Breast. 2015 Aug;24(4):321-30
pubmed: 25840656
Pract Radiat Oncol. 2018 May - Jun;8(3):145-152
pubmed: 29545124
Brachytherapy. 2013 Jul-Aug;12(4):278-84
pubmed: 23664895
J Clin Oncol. 2008 Mar 20;26(9):1419-26
pubmed: 18285604
Lancet. 2016 Jan 16;387(10015):229-38
pubmed: 26494415
Clin Oncol (R Coll Radiol). 2020 May;32(5):279-281
pubmed: 32241520
Eur J Cancer. 2015 Mar;51(4):451-463
pubmed: 25605582
J Clin Oncol. 2007 Aug 1;25(22):3259-65
pubmed: 17577015
Radiother Oncol. 2013 Aug;108(2):197-202
pubmed: 23742961
Lancet Oncol. 2022 Jan;23(1):e21-e31
pubmed: 34973228
JAMA. 2011 Feb 9;305(6):569-75
pubmed: 21304082
Am J Surg. 2007 Oct;194(4):456-62
pubmed: 17826055
Lancet. 2020 May 23;395(10237):1613-1626
pubmed: 32580883
Clin Cancer Res. 2018 Dec 1;24(23):5895-5901
pubmed: 30054280
Int J Radiat Oncol Biol Phys. 2008 Nov 15;72(4):1064-9
pubmed: 18411005
Ann Surg Oncol. 2013 Oct;20(10):3279-85
pubmed: 23975302
Int J Radiat Oncol Biol Phys. 2007 Apr 1;67(5):1299-308
pubmed: 17275202
Pract Radiat Oncol. 2014 Nov-Dec;4(6):466-71
pubmed: 25407870
Med Dosim. 2015 Spring;40(1):21-5
pubmed: 25155215
Lancet. 2019 Dec 14;394(10215):2155-2164
pubmed: 31813636
Nature. 2000 Aug 17;406(6797):747-52
pubmed: 10963602
Int J Radiat Oncol Biol Phys. 2007 Sep 1;69(1):41-8
pubmed: 17707265
JAMA Oncol. 2017 Jan 01;3(1):42-48
pubmed: 27607734
Lancet. 2019 Dec 14;394(10215):2165-2172
pubmed: 31813635
CA Cancer J Clin. 2014 Mar-Apr;64(2):135-52
pubmed: 24357525
Int J Radiat Oncol Biol Phys. 2009 Jul 15;74(4):987-1001
pubmed: 19545784
Radiother Oncol. 2010 Mar;94(3):264-73
pubmed: 20181402
Radiother Oncol. 2010 Mar;94(3):274-9
pubmed: 20181401
Med Dosim. 2013 Spring;38(1):55-9
pubmed: 22901747
N Engl J Med. 2010 Feb 11;362(6):513-20
pubmed: 20147717
Lancet Oncol. 2021 Mar;22(3):309-320
pubmed: 33493433
J Clin Oncol. 1997 Mar;15(3):963-8
pubmed: 9060534
Radiat Oncol. 2020 Mar 30;15(1):71
pubmed: 32228654
Ann Oncol. 2011 Aug;22(8):1736-47
pubmed: 21709140
J Clin Oncol. 2011 Jul 20;29(21):2852-8
pubmed: 21670451
N Engl J Med. 2001 Nov 8;345(19):1378-87
pubmed: 11794170
Int J Radiat Oncol Biol Phys. 2021 Apr 1;109(5):1311-1324
pubmed: 33321192
Brachytherapy. 2013 Jul-Aug;12(4):267-77
pubmed: 23619524
Transl Cancer Res. 2020 Jan;9(Suppl 1):S236-S241
pubmed: 35117967
Eur J Surg Oncol. 2022 Aug;48(8):1692-1698
pubmed: 35241322
Nat Commun. 2020 Jun 26;11(1):3256
pubmed: 32591500
Lancet Oncol. 2013 Dec;14(13):1269-77
pubmed: 24225155
J Clin Oncol. 2001 Apr 15;19(8):2254-62
pubmed: 11304779
Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):e153-9
pubmed: 22560544
Int J Radiat Oncol Biol Phys. 2009 Jun 1;74(2):458-63
pubmed: 19084347
Lancet Oncol. 2013 Apr;14(4):297-305
pubmed: 23491275
Lancet Oncol. 2013 Oct;14(11):1086-1094
pubmed: 24055415
Crit Rev Oncol Hematol. 2018 Nov;131:96-101
pubmed: 30293712
Lancet. 2014 Feb 15;383(9917):603-13
pubmed: 24224997
Radiother Oncol. 2019 Dec;141:329-330
pubmed: 31451284
Breast Care (Basel). 2022 Apr;17(2):224-231
pubmed: 35707177
Med Dosim. 2014 Spring;39(1):18-22
pubmed: 24238837
Lancet. 2017 Sep 9;390(10099):1048-1060
pubmed: 28779963
Cochrane Database Syst Rev. 2010 Nov 10;(11):CD003860
pubmed: 21069678
Strahlenther Onkol. 2022 Jul;198(7):601-611
pubmed: 35527272
Brachytherapy. 2016 Sep-Oct;15(5):607-15
pubmed: 27475478
Strahlenther Onkol. 2020 May;196(5):417-420
pubmed: 32211940
Eur J Cancer. 1996 Apr;32A(4):608-11
pubmed: 8695261
Radiat Oncol. 2010 Oct 04;5:90
pubmed: 20920346
Radiother Oncol. 2019 Aug;137:159-166
pubmed: 31108277
Radiother Oncol. 2014 Jul;112(1):9-16
pubmed: 24813095
Clin Cancer Res. 2020 Aug 1;26(15):4054-4063
pubmed: 32341032
Radiother Oncol. 2011 Aug;100(2):210-4
pubmed: 21497927
Pract Radiat Oncol. 2017 Mar - Apr;7(2):73-79
pubmed: 27866865
J Clin Oncol. 2020 Sep 1;38(25):2830-2838
pubmed: 32484754
Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):1124-30
pubmed: 17967306
BMC Cancer. 2018 Apr 23;18(1):456
pubmed: 29688847
N Engl J Med. 2013 Mar 14;368(11):987-98
pubmed: 23484825
Lancet Oncol. 2015 Jan;16(1):47-56
pubmed: 25500422

Auteurs

Iveta Kolářová (I)

Department of Oncology and Radiotherapy, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Charles University, 500 05 Hradec Králové, Czech Republic.
Faculty of Health Studies, Pardubice University, 532 10 Pardubice, Czech Republic.

Bohuslav Melichar (B)

Department of Oncology, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, 779 00 Olomouc, Czech Republic.

Jaroslav Vaňásek (J)

Faculty of Health Studies, Pardubice University, 532 10 Pardubice, Czech Republic.
Oncology Centre, Multiscan, 532 03 Pardubice, Czech Republic.

Igor Sirák (I)

Department of Oncology and Radiotherapy, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Charles University, 500 05 Hradec Králové, Czech Republic.

Jiří Petera (J)

Department of Oncology and Radiotherapy, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Charles University, 500 05 Hradec Králové, Czech Republic.

Kateřina Horáčková (K)

Faculty of Health Studies, Pardubice University, 532 10 Pardubice, Czech Republic.

Denisa Pohanková (D)

Department of Oncology and Radiotherapy, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Charles University, 500 05 Hradec Králové, Czech Republic.

Zuzana Šinkorová (Z)

Department of Radiobiology, Faculty of Military Health Sciences, University of Defence, 500 01 Hradec Králové, Czech Republic.

Oldřich Hošek (O)

Faculty of Health Studies, Pardubice University, 532 10 Pardubice, Czech Republic.

Milan Vošmik (M)

Department of Oncology and Radiotherapy, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Charles University, 500 05 Hradec Králové, Czech Republic.

Classifications MeSH